Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential
| Image |  |
|---|---|
| Description | scientific article published on 27 October 2009 |
| Author/s |
author: Thomas Unger Björn Dahlöf |
| Publication date | October 27, 2009 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |